Their stated mission is to "connect you with healthcare providers" to facilitate "access to qualified healthcare providers and wellness medications ." Here is a breakdown of the specific claims Brello makes regarding their service, process, and expected results: Access to GLP-1 Medications Brello claims to provide access specifically to Semaglutide and Tirzepatide
Modulates nitric oxide pathways, improving blood flow and nutrient delivery
And earlier this year, when 48-year-old Jake Terry wanted to test the effects of retatrutide, a new but not-yet-approved compound developed by the pharmaceutical giant Eli Lilly, he bought some online and took it to his friends
Many Ozempic users are already familiar with the gastrointestinal side effects of the drug including diarrhea, nausea, vomiting, and stomach pain
If additional glucose control is needed, the dose may be further increased to 1 mg once weekly
For these reasons, GLP-1 analogues have been FDA-approved for treatment of obesity and diabetes, Dr